PFE Market Analysis
Wall Street coverage
third-party contextWall Street coverage
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
7 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeValuation
- Forward P/E
- 8.53
- PEG ratio
- 2.94
- P/B
- 1.58
- P/S (TTM)
- 2.26
- EV/EBITDA
- 11.25
Profitability & growth
- ROE (TTM)
- 8.3%
- Operating margin
- 31.6%
- Revenue growth YoY
- 5.4%
- Dividend yield
- 6.9%
- Beta
- 0.31
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Pfizer Inc
Company profilePfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company commemorates its co-founder, Charles Pfizer (1824-1906). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than 1 billion USD in annual revenues.
Classification
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 66 HUDSON BOULEVARD EAST, NEW YORK, NY
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
